In the aquatic environment, diet is an important route of exposure for the common contaminant and procarcinogen benzo(a)pyrene (BaP). Dietary organisms var'yin their BaP content and in contaminated areas often contain other xenobiotics including cytochrome P4501A inducers.
In the aquatic environment, diet is an important route of exposure for the common contaminant and procarcinogen benzo(a)pyrene (BaP) . Dietary organisms var'yin their BaP content and in contaminated areas often contain other xenobiotics including cytochrome P4501A inducers.
This study eamined the effect of dose and previous dietary exposure to the inducer 3-naphthoflavone (BNF) upon the intestinal metabolism of BaP and the sptemic bioavailability of BaP-derived products in catfish. BaP was administered at 2 and 20 pM into in situ-isolated perflsed intestines of control and BNF-pretreated catfish. The intestine formed an array of metabolites in all treatments including potentially hazardous metabolites such as BaP-7,8 and 9,10 dihydrodiols and 6-methy-BaP. BNF treatment disproportionally increased the contribution of BaP-7,8 and 9,10 dihydrodiols relative to the contributions of other metabolites. A greater percentage of metabolites was evident as conjugates in 2 pM controls, whereas a greater percentage of unconjugated metabolites was evident for 20 pM controls and BNF treatments of both dosages. BNF pretreatment and the higher 20 pM BaP dose resulted in greater bioavailabilit4 with 2.6-5.5-fold and 3.0-6.3-fold s in temically avhlable BaP products, respectively.
Metabolites represented 10.2-23.1% of the increased bioavilability with BNF treatment, saggesting that mechanisms, in addition to induced metabolism, may be operative. These results indicate that intestnal bioavailability, level of biotransformation, and the metabolic profile of BaP-derived products entering the bloed from the intestine may be altered by dose and dietary BNF pretreatment. Key wordk: activation, benzo(a)pyrene; bioavailability, biotransformation, catfish, eimination, in situ preparation, intestine. Environ Health Perspect 106:155-166 (1998).
[ Online 5 February 1998 ] httap://ehpnedt.niess.nih.govldocs/A998/106p155-166kkinow/abaract.html Polynuclear aromatic hydrocarbons (PAHs) are frequently found as contaminants in impacted aquatic environments. These compounds have been associated with areas that demonstrate a high tumor prevalence in wild fish populations (1) (2) (3) . The carcinogenicity of PAHs is a well-known consequence of their metabolic activation (4) . Among the various PAHs, the model compound benzo(a)pyrene (BaP) has received the most attention in fish species, with a primary focus on hepatic metabolism and adduct formation (5, 6) . BaP has been shown experimentally to be carcinogenic to fish following both waterborne (7) and oral exposures (8) .
The hydrophobicity and environmental partitioning (9) of BaP, as well as its accumulation in infaunal invertebrates (10, 11) , suggest that the diet may be an important route of exposure for aquatic species.
Studies examining various levels in the aquatic food chain have demonstrated not only the presence of BaP in diet and tissues but the biotransformation of BaP by lower organisms and the subsequent food chain transfer of BaP molar equivalents (Meq) to higher organisms (12) (13) (14) . (BaP molar equivalent is defined here as BaP and BaPderived metabolites compositely quantified by radioactivity and placed on an equal molar basis using BaP's specific activity.)
Dietary BaP may also undergo biotransformation by the intestine of the consumer before entering the systemic circulation (15) . Intestines of fish are capable of a wide variety of biotransformation reactions, some of which respond to dietary cytochrome P4501A (CYPIA) inducers (16) . Dietary induction studies in both flounder (17) and catfish (16) indicate that under conditions of low inducer concentrations, select biotransformation activities in the intestine may equal or even exceed corresponding hepatic activities. Such induction effects may potentially alter the degree and pathway of metabolism. Similarly, in vitro BaP studies with flounder intestinal homogenates suggest that the biotransformation pathways and products formed in the intestine may be altered by the BaP dose (17). BaP may be activated or alternatively detoxified by metabolically favored pathways. These findings suggest that the balance between toxification and detoxification on first-pass metabolism through the intestine may depend on dose and previous exposure history.
Objectives of the present study were to examine the intestinal metabolism and bioavailability of BaP in context of the products formed under varying conditions of dose and previous exposure history. These goals were addressed using an in situ isolated perfused intestinal model (catfish). BaP dosages used were based on Km determinations of relevant biotransformation enzymes in the intestine. Dietary pretreatment was accomplished using the CYPIA inducer j-naphthoflavone (BNF) at concentrations in the diet that would induce the intestine but not the liver. Murray , UT) was fed to fish before experimental treatment. On initiation of experimental treatment, control fish were maintained on trout chow coated with corn oil (100 pl corn oil/100 g chow), whereas fish to be induced were fed 1 mg BNF/100 pl corn oil/100 g chow. Both dietary groups were maintained on appropriate experimental diets at 30 g feed/ kg/day for 14 days before surgical manipulation. Fish were fasted 24 hr before surgery and in situ experimentation.
Materials and Methods
Intestinal microsomes were prepared from control and BNF-exposed catfish for use in in vitro studies of BaP positional metabolism and monooxygenase Km and Vm determinations. Catfish were immobilized in ice water and sacrificed by severing the spinal cord (n = 4/treatment). Intestines were removed, rinsed thoroughly with ice-cold buffer 1 [0.25 M sucrose, 5 mM EDTA, 0.05M Tris-Cl, pH 7.4, 0.2 mM phenylmethyl sulfonyl fluoride (PMSF)] to remove contents, and cut open; mucosal cells were then removed by scraping with a scalpel. The mucosa was placed in 10 ml buffer 1 and the cells were sedimented at 2,000 x g, weighed, and homogenized in 4 vol buffer 1 . Washed microsomal fractions were prepared by differential centrifugation using the procedure described by James and Little (18) .
[3H]-BaP for enzymatic assays and other standards was purchased from Chemsyn (a function of the NCI The intestine was exposed by a longitudinal ventral midline incision. A ventral loop of proximal intestine starting 10 cm caudad to the pylorus and extending aborally approximately 20 cm was used for the preparation (Fig. 1 ). The afferent (supply) vessel, a branch of the coeliacomesenteric artery, and the corresponding efferent (drainage) vessel perfusing the prospective intestinal segment as well as potential collateral vessels were identified and isolated, and suture (00 silk) was placed loosely around each. Once ligatures were in place, blood was drawn from the caudal vein into a syringe containing citrate anticoagulant. The syringe, with a total of 10 ml blood and 1 ml oxygen (as determined by preliminary blood gas studies), was placed on an orbital mixer that provided gentle agitation for the cells.
The isolated afferent vessel was cannulated using anticoagulant-filled PE-50 (polyethylene) tubing. showed that the major metabolites were 3-OH-, 7-OH-, and 9-OH-BaP, BaP-diones, BaP-7,8-dihydrodiol (BaP-7,8-D), and BaP-9, 10-dihydrodiol (BaP-9, 10-D) ( (Table 3 ). The intestinal microsomes from BNF-treated catfish also had a 6.2-fold higher EROD activity (Table 3 were used for dosage considerations in the in situ intestinal preparations. Total BaP Meq entering the systemic circulation in the in situ intestinal preparation varied with dose and with BNF treatment of the fish. A 10-fold increase in BaP dose administered resulted in a significant 3.0-6.3-fold increase in systemically available (blood) BaP Meq (Fig. 2) . BNF pretreatment resulted in significant 5.5-and 2.6-fold increases in systemically available BaP Meq for the 2 and 20 IM doses, respectively (Fig.  2) . Analysis of radioactivity entering the systemic circulation for each of the in situ treatments indicated that the increase in BaP (16) compartments than in the liver, especially in uninduced animals. Predictably, an attempt with liver microsomes to detect the 6-oxy-BaP free radical in fish was largely unsuccessful (6). Non-P450-dependent metabolic routes and transport differences in the intestine and the vasculature are plausible explanations for the prominent role of diones in these select studies and samples.
Conjugates represented a major component in the blood and intestinal mucosa, accounting for between 26.5 and 65.0% and 31. 4 (16) . In addition, BNF treatment also increases CYP1A production of BaP-7,8-oxide and BaP-9,10-oxide, which in turn leads to increased BaP-7,8-D and 9,10-D formation, as well as 7-and 9-hydroxy BaP (Fig. 3) . The resulting BaP-dihydrodiols are poorer substrates for glucuronidation than BaP-phenols (68), which leads to a buildup of unconjugated dihydrodiols relative to hydroxy-BaP. Strict The water-soluble fractions and HPLC peaks eluting before 10 min in the present study are likely to include a mixture of sulfate, glucuronide, and glutathione conjugates of the oxidative metabolites of BaP (Fig. 4) . The large number of potential conjugates from BaP-phenols, BaP-dihydrodiols, and BaP-oxides, in light of their overlapping physicochemical properties, made isolation of individual polar conjugates difficult based on retention characteristics. Incubation of radioactivity eluted from the C18 matrix beads by water and methanol with 1-glucuronidase or sulfatase suggested that up to 20% of the conjugates found were a mixture of glucuronides and sulfates. More than 80% of the conjugates were not hydrolyzed by sulfatase or P-glucuronidase, suggesting that these were glutathione conjugates and further metabolites of glutathione conjugates. Others have shown that glutathione conjugates were the major metabolites of orally administered BaP (0.1-2 mg/kg) excreted in vivo in bile of several fish species (6, 69) . In addition to the water and methanol fractions eluted from the C18 matrix beads, there is evidence that a portion of the unidentified radioactivity not eluted from the C18 beads included breakdown products of glucuronide and glutathione conjugates [ Table 1 ; Tong and James, unpublished observations; (70)].
Intestinal microflora are thought to be minimal contributors to the observed findings. There is no evidence that these organisms contain the P450s or conjugative enzymes involved in BaP oxidation or conjugation [ Fig. 4; (71-73) ]. Microflora, however, do contain reductive and hydrolytic enzymes. Degradative reactions such as dehydroxylation and hydrolysis of glucuronides may decrease postinfusate metabolite concentrations. This effect is thought to be minimized because fasting as well as dearing fecal material would be expected to reduce bacterial numbers and their metabolic contribution (74).
A considerable degree of variation was evident in all aspects of these studies. Fish are inherently variable relative to a number of key biotransformation enzymes (75). Intestinal studies pose other challenges. Catfish because of their poikilothermic nature and feeding behavior show variations in food consumption and hence in in vivo intestinal induction. This is problematic because healthwise they do not tolerate long-term repetitive handling as in gavage feeding. In addition, variable boundaries imposed by the circulation in perfusion studies, the somewhat variable length of the perfusion segment because of the state of relaxation and contraction of the in situ intestine, the wide scope of available biotransformation pathways, and the dynamic nature (turnover) of the mucosal cells containing uptake and biotransformational sites all contribute to variability.
In summary, the systemic bioavailability of BaP molar equivalents from the intestine was significantly greater with higher BaP dosages and BNF pretreatment. BNF generally increased metabolite production; however, increases in bioavailability could not be accounted for solely by changes in metabolism. Intestinal formation and systemic uptake of potentially hazardous metabolites and detoxification products of BaP in the catfish intestine appear to be related to dose and BNF pretreatment through an interplay of primary and secondary biotransformation pathways. Conjugates were proportionally favored under low-dose uninduced conditions, whereas benzo-ring diols were proportionally more important upon BNF preexposure. Clearly the interplay of dose, exogenous agents, and intestinal function are important factors in the uptake, disposition, and risk associated with dietary BaP. .:.. 
